• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lncRNA 跨九种癌症类型的 DNA 共甲基化分析揭示了癌症中新型潜在的表观遗传生物标志物。

DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer.

机构信息

College of Bioinformatics Science & Technology, Harbin Medical University, Harbin 150081, PR China.

School of Life Science, Faculty of Science, The Chinese University of Hong Kong, PR China.

出版信息

Epigenomics. 2019 Aug;11(10):1177-1190. doi: 10.2217/epi-2018-0138. Epub 2019 Jul 26.

DOI:10.2217/epi-2018-0138
PMID:31347388
Abstract

The potential functions and prognostic value of lincRNAs with co-methylation events are explored in 9 cancer types. Here, we evaluated the co-methylation events in promoter and gene-body regions between two lincRNAs across 9 cancer types by constructing a systematic biological framework. The co-methylation events in both promoter and gene-body regions tended to be highly cancer specific. Patient samples could be separated by tumor and normal types according to the eigengenes of universal co-methylation clusters. Functional enrichment results revealed the lincRNAs that brought promoter and gene-body co-methylation events that affected cancer progress through participating in different pathways and could serve as potential prognostic biomarkers. The study provides new insight into the epigenetic regulation in cancer and leads to a potential new direction for epigenetic biomarker discovery.

摘要

探讨了共甲基化事件相关 lincRNAs 的潜在功能和预后价值,涉及 9 种癌症类型。在这里,我们通过构建系统的生物学框架,评估了两种 lincRNAs 在启动子和基因体区域之间的共甲基化事件。启动子和基因体区域的共甲基化事件往往具有高度的癌症特异性。根据通用共甲基化簇的特征基因,可以根据肿瘤和正常类型对患者样本进行分离。功能富集结果显示,lincRNAs 通过参与不同的途径,带来启动子和基因体共甲基化事件,影响癌症进展,可以作为潜在的预后生物标志物。该研究为癌症中的表观遗传调控提供了新的见解,并为表观遗传生物标志物的发现开辟了一个潜在的新方向。

相似文献

1
DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer.lncRNA 跨九种癌症类型的 DNA 共甲基化分析揭示了癌症中新型潜在的表观遗传生物标志物。
Epigenomics. 2019 Aug;11(10):1177-1190. doi: 10.2217/epi-2018-0138. Epub 2019 Jul 26.
2
Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.频繁DNA共甲基化模式的泛癌分析揭示了多种癌症中一致的表观遗传景观变化。
BMC Genomics. 2017 Jan 25;18(Suppl 1):1045. doi: 10.1186/s12864-016-3259-0.
3
Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.通过整合肺腺癌中 lincRNA 表达和拷贝数变异来系统识别 lincRNA 预后生物标志物。
Int J Cancer. 2019 Apr 1;144(7):1723-1734. doi: 10.1002/ijc.31865. Epub 2018 Dec 12.
4
Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.泛癌分析揭示与肿瘤诊断、亚型分类及预后相关的长基因间非编码RNA
EBioMedicine. 2016 May;7:62-72. doi: 10.1016/j.ebiom.2016.03.023. Epub 2016 Mar 19.
5
A novel reannotation strategy for dissecting DNA methylation patterns of human long intergenic non-coding RNAs in cancers.一种用于剖析癌症中人类长链基因间非编码RNA的DNA甲基化模式的新型重新注释策略。
Nucleic Acids Res. 2014 Jul;42(13):8258-70. doi: 10.1093/nar/gku575. Epub 2014 Jul 10.
6
Large-scale analysis of methylation reveals its potential as biomarker for breast cancer.大规模甲基化分析揭示了其作为乳腺癌生物标志物的潜力。
Clin Epigenetics. 2018 Apr 11;10:51. doi: 10.1186/s13148-018-0479-y. eCollection 2018.
7
Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.前列腺癌中长链基因间非编码RNA(lincRNA)模块生物标志物的发现与特征分析:RNA测序数据的综合分析
BMC Genomics. 2015;16 Suppl 7(Suppl 7):S3. doi: 10.1186/1471-2164-16-S7-S3. Epub 2015 Jun 11.
8
Interplay between regulation by methylation and noncoding RNAs in cancers.癌症中甲基化调控与非编码RNA之间的相互作用。
Eur J Cancer Prev. 2018 Jul;27(4):418-424. doi: 10.1097/CEJ.0000000000000433.
9
Profiling Noncoding RNAs in Cancer.癌症中非编码 RNA 分析。
Cancer Discov. 2016 Jan;6(1):OF10. doi: 10.1158/2159-8290.CD-NB2015-154. Epub 2015 Nov 13.
10
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.急性髓系白血病异常 DNA 甲基化谱分析揭示了与表观遗传或遗传相关的富含 CG 区域的亚类。
Leukemia. 2019 Jan;33(1):26-36. doi: 10.1038/s41375-018-0165-2. Epub 2018 Jun 20.

引用本文的文献

1
Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers.全癌种长链非编码RNA甲基化失调揭示表观遗传生物标志物
Front Cell Dev Biol. 2022 May 27;10:882698. doi: 10.3389/fcell.2022.882698. eCollection 2022.
2
ncFANs v2.0: an integrative platform for functional annotation of non-coding RNAs.ncFANs v2.0:一个用于非编码 RNA 功能注释的综合平台。
Nucleic Acids Res. 2021 Jul 2;49(W1):W459-W468. doi: 10.1093/nar/gkab435.
3
Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
lncRNA 扰动三联体的综合分析揭示了跨癌症类型的新型预后特征。
Int J Mol Sci. 2020 Aug 24;21(17):6087. doi: 10.3390/ijms21176087.